TrialDiabetes care2020

Efficacy and Safety Over 2 Years of Exenatide Plus Dapagliflozin in the DURATION-8 Study: A Multicenter, Double-Blind, Phase 3, Randomized Controlled Trial.

Serge A Jabbour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.